Vision at Johnson & Johnson has appointed Caroline Blackie, MS, OD, PhD, as vice president of medical affairs. Dr. Blackie has been with the company for 8 years and previously served as senior medical director and interim head of medical affairs. She brings experience in direct patient care and scientific research, with a track record of leadership in clinical and medical affairs in the vision industry.

The company has also appointed Paul Lisenby as global head of research and development, effective August 4, 2025. Mr. Lisenby brings global expertise, having served as a product development leader for several large medical technology companies. According to the company, he will leverage his track record of cross-functional leadership in new product development to drive the technology pipeline and increase the company’s cadence of launching breakthrough innovations in eye health.